Genygi Life Sciences Private Limited
New Delhi, Delhi
GST No. 07AAKCP9586B1Z0
TrustSEAL Verified
Call 07949372432 62% Response Rate
SEND EMAIL
Product Details:
| Strength | 60 mg |
| Pack Size | 30 Tablets |
| Treatment | Treat hepatocellular cancer |
| Form | Tablet |
| Country of Origin | Made in India |
| Prescription/Non-prescription | Prescription |
| Brand | Cabozer |
| Manufacturer | Aprazer Healthcare Private Limited |
Cabozer (Cabozantinib 60 mg) is a potent oral anticancer medication used for the treatment of advanced renal cell carcinoma (RCC), hepatocellular carcinoma (HCC), and certain types of thyroid cancer. It works by inhibiting multiple tyrosine kinases involved in tumor growth and angiogenesis, helping to slow the spread of cancer cells.
Key Features:
Trusted formulation from Genygi Life Sciences
High efficacy in targeted cancer therapy
Convenient oral tablet form
Manufactured under strict GMP compliance
Indications:
Advanced renal cell carcinoma (RCC)
Hepatocellular carcinoma (HCC) after prior sorafenib treatment
Progressive, metastatic medullary thyroid cancer
Storage:
Store in a cool, dry place below 25°C. Protect from moisture and direct sunlight.
Disclaimer:
To be sold by retail on the prescription of a qualified oncologist or medical specialist only.